Welcome to the SeraCare Investor Center

 

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics.

Our company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking, and contract research services. 

SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly-regulated life sciences industry.

Latest News
06/24/09SeraCare Life Sciences Launches First-to-Market HPV Genotype Performance PanelPrinter Friendly Version
05/12/09SeraCare Reports Second Quarter Fiscal Year 2009 ResultsPrinter Friendly Version
04/22/09SeraCare Life Sciences Presents Data Supporting the Development of New Diagnostic Control Products at Clinical Virology SymposiumPrinter Friendly Version
04/14/09SeraCare Life Sciences Names Harold S. Blue to Board of DirectorsPrinter Friendly Version
More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
SeraCare Stock Price
 
SRLS (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$1.19
Change (%)0.00 (0.00%)
Volume0
Data as of 07/01/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Track Our Progress
 

Featured Report 2008 10-k

Receive Email Alerts when certain information is posted Sign up

Upcoming Events View